Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Bogaievsky

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Fundamental & Clinical Pharmacology|January 1, 1990
With whom does the French drug industry want to work for phase I?Y Bogaievsky
Journal De Pharmacologie|October 1, 1980
[Comparative pharmacological activity of triamcinolone acetonide and of a new topical steroid: amcinonide, after percutaneous or oral administration (author's transl)]J Wepierre, Y Bogaievsky
Therapie|March 1, 1989
[Writing the clinical trial report]Y Bogaievsky, J F Henry, A Kher
Clinical and Experimental Pharmacology & Physiology|November 1, 1974
Blockade of the central hypotensive effect of clonidine by alpha-adrenoreceptor and antagonists in rats, rabbits and dogsD Bogaievsky, Y Bogaievsky, D Tsoucaris-Kupfer, et al.
L'Encephale|January 1, 1983
[Pharmacoclinical comparison of 2 dosage forms of trihexyphenidyl]S Garbarg, J P Devissaguet, M Prost, et al.
Therapie|May 1, 1984
[Comparative pharmacokinetic study of 2 galenic forms of 5 mg trihexyphenidyl; tablets (Artane) and sustained-release capsules (Parkinane retard)]J P Devissaguet, S Garbarg, M Prost, et al.
Thrombosis and Haemostasis|December 1, 1996
The antithrombotic potential of dalteparin in man assessed indirectly by Wessler's techniqueJ Millet, J Theveniaux, G Tachon, et al.
Circulation Research|June 1, 1976
Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rateM Laubie, B Delbarre, D Bogaievsky, et al.
Atherosclerosis|December 1, 1990
Postprandial lipemia, fenofibrate and coronary artery diseaseH S Simpson, C M Williamson, T Olivecrona, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Fundamental & Clinical Pharmacology|January 1, 1990
With whom does the French drug industry want to work for phase I?Y Bogaievsky
Journal De Pharmacologie|October 1, 1980
[Comparative pharmacological activity of triamcinolone acetonide and of a new topical steroid: amcinonide, after percutaneous or oral administration (author's transl)]J Wepierre, Y Bogaievsky
Therapie|March 1, 1989
[Writing the clinical trial report]Y Bogaievsky, J F Henry, A Kher
Clinical and Experimental Pharmacology & Physiology|November 1, 1974
Blockade of the central hypotensive effect of clonidine by alpha-adrenoreceptor and antagonists in rats, rabbits and dogsD Bogaievsky, Y Bogaievsky, D Tsoucaris-Kupfer, et al.
L'Encephale|January 1, 1983
[Pharmacoclinical comparison of 2 dosage forms of trihexyphenidyl]S Garbarg, J P Devissaguet, M Prost, et al.
Therapie|May 1, 1984
[Comparative pharmacokinetic study of 2 galenic forms of 5 mg trihexyphenidyl; tablets (Artane) and sustained-release capsules (Parkinane retard)]J P Devissaguet, S Garbarg, M Prost, et al.
Thrombosis and Haemostasis|December 1, 1996
The antithrombotic potential of dalteparin in man assessed indirectly by Wessler's techniqueJ Millet, J Theveniaux, G Tachon, et al.
Circulation Research|June 1, 1976
Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rateM Laubie, B Delbarre, D Bogaievsky, et al.
Atherosclerosis|December 1, 1990
Postprandial lipemia, fenofibrate and coronary artery diseaseH S Simpson, C M Williamson, T Olivecrona, et al.
Pageof 1